Crossref
Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel
Dissolution Technologies · 2022 · 29 (1) · 6-20
DOI: 10.14227/dt290122p6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dissolution Technologies, 2022. Verfasst von Matthias G Wacker und 4 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wacker, M. G., Lu, X., Burke, M., Nir, L., & Fahmy, R. (2022). Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel. Dissolution Technologies, 29(1), 6-20. https://doi.org/10.14227/dt290122p6
Vancouver
Wacker MG, Lu X, Burke M, Nir L, Fahmy R. Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel. Dissolution Technologies. 2022;29(1):6-20. doi:10.14227/dt290122p6
BibTeX
@article{Wacker2022,
author = {Wacker, Matthias G and Lu, Xujin and Burke, Matt and Nir, lshai and Fahmy, Raafat},
title = {Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel},
journal = {Dissolution Technologies},
year = {2022},
volume = {29},
number = {1},
pages = {6--20},
doi = {10.14227/dt290122p6}
}
EUVIMED